Source: Annals of Oncology. Conference titles: Congress Scientific Comitee/ESMO. Unidade: FM
Subjects: QUIMIOTERAPIA ADJUVANTE, CARCINOMA DE CÉLULAS ESCAMOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, G. et al. Adjuvant chemoradiation (CRT) in head and neck squamous cell carcinoma (HNSCC) patients presenting with high or intermediate risk features and delayed overall treatment time (OTT). Annals of Oncology. Dordrecht: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 07 nov. 2024. , 2008APA
Castro, G., Maistro, S., Siqueira, S. A. C., Snitcovsky, I., Villar, R., Pasini, F. S., et al. (2008). Adjuvant chemoradiation (CRT) in head and neck squamous cell carcinoma (HNSCC) patients presenting with high or intermediate risk features and delayed overall treatment time (OTT). Annals of Oncology. Dordrecht: Faculdade de Medicina, Universidade de São Paulo.NLM
Castro G, Maistro S, Siqueira SAC, Snitcovsky I, Villar R, Pasini FS, Mangone FRR, Ferraz AR, Federico MHH. Adjuvant chemoradiation (CRT) in head and neck squamous cell carcinoma (HNSCC) patients presenting with high or intermediate risk features and delayed overall treatment time (OTT). Annals of Oncology. 2008 ; 19 223.[citado 2024 nov. 07 ]Vancouver
Castro G, Maistro S, Siqueira SAC, Snitcovsky I, Villar R, Pasini FS, Mangone FRR, Ferraz AR, Federico MHH. Adjuvant chemoradiation (CRT) in head and neck squamous cell carcinoma (HNSCC) patients presenting with high or intermediate risk features and delayed overall treatment time (OTT). Annals of Oncology. 2008 ; 19 223.[citado 2024 nov. 07 ]
